Wikidata entity: Q66077946
Quantities
| P2899 | minimum age | 50 |
| P1132 | number of participants | 20 |
| P6099 | clinical trial phase | ... | Q5452194 (phase I clinical trial) | phase I clinical trial |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2020-02-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q1752891 (polymyalgia rheumatica) | polymyalgia rheumatica |
| P4844 | research intervention | ... | Q424972 (prednisone) | prednisone |
| P6153 | research site | ... | Q126412 (Massachusetts General Hospital) | Massachusetts General Hospital |
| P1813 | short name | Monolingualtext | UGCA | ??? |
| P580 | start time | ... | 2016-12-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Open Label Study to Test the Safety and Efficacy of Ustekinumab in Patients With Giant Cell Arteritis | ??? |
| P3098 | ClinicalTrials.gov ID | NCT02955147 |
Why not click here or view trends?
log id: 4852395